167 related articles for article (PubMed ID: 7827902)
101. Comparison of positron emission tomography and computed tomography in detection of recurrent and metastatic colorectal cancer.
Cohen AM
Ann Surg Oncol; 1997 Dec; 4(8):610. PubMed ID: 9416405
[No Abstract] [Full Text] [Related]
102. Regarding "Survival Outcomes in Asymptomatic Patients with Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging".
Macbeth F; Treasure T
Oncologist; 2017 Nov; 22(11):1411. PubMed ID: 28798269
[TBL] [Abstract][Full Text] [Related]
103. The value of CT in malignant colonic tumors.
Ellert J; Kreel L
J Comput Tomogr; 1980 Sep; 4(3):225-40. PubMed ID: 7261655
[TBL] [Abstract][Full Text] [Related]
104. The role of nuclear medicine in the staging and management of liver metastases.
Lonneux M; Jamar F
Acta Chir Belg; 2003 Oct; 103(5):448-51. PubMed ID: 14653026
[No Abstract] [Full Text] [Related]
105. Does colon cancer ever metastasize to bone first? a temporal analysis of colorectal cancer progression.
Roth ES; Fetzer DT; Barron BJ; Joseph UA; Gayed IW; Wan DQ
BMC Cancer; 2009 Aug; 9():274. PubMed ID: 19664211
[TBL] [Abstract][Full Text] [Related]
106. The role of positron emission tomography in gastrointestinal imaging.
Moadel RM; Blaufox MD; Freeman LM
Gastroenterol Clin North Am; 2002 Sep; 31(3):841-61. PubMed ID: 12481734
[TBL] [Abstract][Full Text] [Related]
107. Whole-body CT screening for cancer and coronary disease: does it pass the test?
Modic MT; Obuchowski N
Cleve Clin J Med; 2004 Jan; 71(1):47-56. PubMed ID: 14740968
[TBL] [Abstract][Full Text] [Related]
108. Chest computed tomography screening in colorectal cancer patients.
Chartrand-Lefebvre C; Lapointe R; Samson L; Cordeau MP; Prenovault J
World J Surg; 2009 Jun; 33(6):1325-6; author reply 1327. PubMed ID: 19137364
[No Abstract] [Full Text] [Related]
109. Advances in imaging of colorectal cancer.
Padhani AR
Crit Rev Oncol Hematol; 1999 May; 30(3):189-99. PubMed ID: 10439064
[No Abstract] [Full Text] [Related]
110. Data analysis.
Gibbs AC
Clin Radiol; 2002 Dec; 57(12):1128; author reply 1128. PubMed ID: 12475541
[No Abstract] [Full Text] [Related]
111. Blood CEA levels for detecting recurrent colorectal cancer.
Nicholson BD; Shinkins B; Pathiraja I; Roberts NW; James TJ; Mallett S; Perera R; Primrose JN; Mant D
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011134. PubMed ID: 26661580
[TBL] [Abstract][Full Text] [Related]
112. The role of positron emission tomography in colorectal carcinoma.
Nachar OM
Ochsner J; 2002; 4(3):146-55. PubMed ID: 22822338
[TBL] [Abstract][Full Text] [Related]
113. Surgical management of colorectal lung metastasis.
Villeneuve PJ; Sundaresan RS
Clin Colon Rectal Surg; 2009 Nov; 22(4):233-41. PubMed ID: 21037814
[TBL] [Abstract][Full Text] [Related]
114. FDG-PET in colorectal cancer.
de Geus-Oei LF; Ruers TJ; Punt CJ; Leer JW; Corstens FH; Oyen WJ
Cancer Imaging; 2006 Oct; 6(Spec No A):S71-81. PubMed ID: 17114081
[TBL] [Abstract][Full Text] [Related]
115. Is 3'-deoxy-3'-(18)F-fluorothymidine a better marker for tumour response than (18)F-fluorodeoxyglucose?
Reske SN; Deisenhofer S
Eur J Nucl Med Mol Imaging; 2006 Jul; 33 Suppl 1():38-43. PubMed ID: 16721567
[TBL] [Abstract][Full Text] [Related]
116. The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin.
Scott CL; Kudaba I; Stewart JM; Hicks RJ; Rischin D
Mol Imaging Biol; 2005; 7(3):236-43. PubMed ID: 15912428
[TBL] [Abstract][Full Text] [Related]
117. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
Selzner M; Hany TF; Wildbrett P; McCormack L; Kadry Z; Clavien PA
Ann Surg; 2004 Dec; 240(6):1027-34; discussion 1035-6. PubMed ID: 15570208
[TBL] [Abstract][Full Text] [Related]
118. [PET/CT for colorectal and hepatic tumors].
Stollfuss J; Wieder H; Rummeny E; Schwaiger M
Radiologe; 2004 Nov; 44(11):1068-78. PubMed ID: 15517139
[TBL] [Abstract][Full Text] [Related]
119. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).
Fernandez FG; Drebin JA; Linehan DC; Dehdashti F; Siegel BA; Strasberg SM
Ann Surg; 2004 Sep; 240(3):438-47; discussion 447-50. PubMed ID: 15319715
[TBL] [Abstract][Full Text] [Related]
120. Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.
Böhm B; Voth M; Geoghegan J; Hellfritzsch H; Petrovich A; Scheele J; Gottschild D
J Cancer Res Clin Oncol; 2004 May; 130(5):266-72. PubMed ID: 14767761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
